1. Arworn, S, Orrapin, S, Chakrabandhu, B, et al. Aorto-enteric fistula after endovascular abdominal aortic aneurysm repair for Behcet’s disease patient: a case report. EJVES Short Rep 2018; 39: 54–57
Google Scholar | Crossref | Medline2. Dorigo, W, Pulli, R, Azas, L, et al. Early and long-term results of conventional surgical treatment of secondary aorto-enteric fistula. Eur J Vasc Endovasc Surg 2003; 26: 512–518.
Google Scholar | Crossref | Medline | ISI3. Kahlberg, A, Rinaldi, E, Piffaretti, G. et al. MAEFISTO collaborators , Results from the multicenter study on aortoenteric fistulization after stent grafting of the abdominal aorta (MAEFISTO). J Vasc Surg 2016; 64: 313e20.
Google Scholar | Crossref4. Niaz, OS, Rao, A, Abidia, A, et al. Surgical and medical interventions for abdominal aortic graft infections. Cochrane Database Syst Rev 2020; 8: CD013469. doi: 10.1002/14651858.CD013469.pub2
Google Scholar | Crossref | Medline5. OTA, Lyons, Baguneid, M, Barwick, TD. Diagnosis of aortic graft infection: a case definition by the Management of Aortic Graft Infection Collaboration (MAGIC). Eur J Vasc Endovas Surg 2016; 52(6): 758–763.
Google Scholar | Crossref | Medline6. Fitzgerald, S, Kelly, C, Humphreys, H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother 2005; 56: 996–999
Google Scholar | Crossref | Medline | ISI7. Prompetchara, E, Ketloy, C, Palaga, T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Pac J Allergy Immunol 2020; 38(1): 1–9. doi: 10.12932/AP-200220-0772.
Google Scholar | Crossref | Medline8. Wang, D, Hu, B, Hu, C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061.
Google Scholar | Crossref | Medline9. Zamboni, P . COVID-19 as a vascular disease: lesson learned from imaging and lood biomarkers. Diagnostics (Basel) 2020; 10(7): 440. doi: 10.3390/diagnostics10070440
Google Scholar | Crossref10. Chopra, A, Cieciura, L, Modrall, JG, et al. Twenty-year experience with aorto-enteric fistula repair: gastrointestinal complications predict mortality. J Am Coll Surg 2017; 225(1): 9–18.
Google Scholar | Crossref | Medline11. Vogel, T, Symons, R, Flum, D. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008; 47(2): 264–269.
Google Scholar | Crossref | Medline | ISI12. Pipinos, II, Carr, JA, Haithcock, BE, et al. Secondary aortoenteric fistula. Ann Vasc Surg 2000; 14: 688–696.
Google Scholar | Crossref | Medline | ISI13. Parry, DJ, Waterworth, A, Kessel, D, et al. Endovascular repair of an inflammatory abdominal aortic aneurysm complicated by aortoduodenal fistulation with an unusual presentation. J Vasc Surg 2001; 33: 874–879.
Google Scholar | Crossref | Medline | ISI14. Zaki, M, Tawfick, W, Alawy, M, et al. Secondary aortoduodenal fistula following endovascular repair of inflammatory abdominal aortic aneurysm due to Streptococcus anginosus infection: a case report and literature review. Int J Surg Case Rep 2014; 5(10): 710–713. doi: 10.1016/j.ijscr.2013.10.016. Epub 2014 Aug 12.
Google Scholar | Crossref | Medline15. Kadhim, MMK, Rasmussen, JBG, Eiberg, JP. Aorto-enteric fistula 15 years after uncomplicated endovascular aortic repair with unforeseen onset of endocarditis. EJVES Short Rep 2016; 31: 16–18.
Google Scholar | Crossref | Medline16. Chenu, C, Marcheix, B, Barcelo, C, et al. Aorto-enteric fistula after endovascular abdominal aortic aneurysm repair: case report and review. Eur J Vasc Endovasc Surg 2009; 37: 401–406.
Google Scholar | Crossref | Medline17. O’Connor, S, Andrew, P, Batt, M, et al. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg 2006; 44(1): 38–45.
Google Scholar | Crossref | Medline | ISI18. Koda, Y, Murakami, H, Yoshida, M, et al. Secondary aorto-enteric fistula and type II endoleak five years after endovascular abdominal aortic aneurysm repair. EJVES Short Rep 2019; 43: 12–17.
Google Scholar | Crossref | Medline19. Robson, B . COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance. Comput Biol Med 2020; 121: 103749. doi: 10.1016/j.compbiomed.2020.103749. Epub 2020 Apr 11.
Google Scholar | Crossref | Medline20. Bortolotti, D, Gentili, V, Rizzo, S, et al. SARS-CoV-2 spike 1 protein controls natural killer cell activation via the HLA-E/NKG2A pathway. Cells 2020; 9(9): 1975. doi: 10.3390/cells9091975
Google Scholar | Crossref21. Soy, M, Keser, G, Atagündüz, P, et al. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 2020; 39(7): 2085–2094. doi: 10.1007/s10067-020-05190-5. Epub 2020 May 30.
Google Scholar | Crossref | Medline22. Gu, J, Han, B, Wang, J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; 158: 1518–1519.
Google Scholar | Crossref | Medline23. Ding, Y, He, L, Zhang, Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 2020; 203: 622–630. doi: 10.1002/path.1560
Google Scholar | Crossref24. Ojetti, V, Saviano, A, Covino, M, et al. GEMELLI AGAINST COVID‐19 group , COVID-19 and intestinal inflammation: role of fecal calprotectin. Dig Liver Dis 2020; 52(11): 1231–1233. doi: 10.1016/j.dld.2020.09.015. Epub 2020 Sep 22.
Google Scholar | Crossref | Medline25. Zidi, I . Puzzling out the COVID-19: therapy targeting HLA-G and HLA-E. Hum Immunol 2020; 81(12): 697–701. doi: 10.1016/j.humimm.2020.10.001. Epub 2020 Oct7.
Google Scholar | Crossref | Medline26. Rizzo, R, Neri, LM, Simioni, C, et al. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient. Clin Microbiol Infect 2021; 27(6): 936–937. doi: 10.1016/j.cmi.2021.01.012. Epub 2021 Jan 16.
Google Scholar | Crossref | Medline27. Zhang, S, Gan, J, Chen, BG, et al. Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence. Clin Transl Immunol 2020; 9(5): e1128. doi: 10.1002/cti2.1128. eCollection 2020 May.
Google Scholar | Crossref | Medline28. Urosevic, M, Kurrer, MO, Kamarashev, J, et al. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 2001; 159: 817.
Google Scholar | Crossref | Medline | ISI29. Rizzo, R, Bortolotti, D, Bolzani, S, et al. HLA-G molecules in autoimmune diseases and infections. Front Immunol 2014; 5: 592. doi: 10.3389/fimmu.2014.00592
Google Scholar | Crossref | Medline30. Spencer, JV, Lockridge, KM, Barry, PA, et al. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 2002; 76: 1285–1292. doi: 10.1128/JVI.76.3.1285-1292.2002
Google Scholar | Crossref | Medline31. Li, C, Toth, I, Schulze Zur Wiesch, J, et al. Functional characterization of HLA-G+ regulatory T cells in HIV-1 infection. PLoS Pathog 2013; 9: e1003140.
Google Scholar | Crossref | Medline32. Yan, WH, Lin, A, Chen, BG, et al. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis 2009; 200: 820–826.
Google Scholar | Crossref | Medline33. Amiot, L, Vu, N, Rauch, M, et al. Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis. J Hepatol 2014; 60: 245–252.
Google Scholar | Crossref | Medline34. Zidi, I, Kharrat, N, Abdelhedi, R, et al. Nonclassical human leukocyte antigen (HLA-G, HLA-E, and HLA-F) in coronary artery disease. Hum Immunol 2016; 77(4): 325–329. doi: 10.1016/j.humimm.2016.01.008. Epub 2016 Jan 11.
Google Scholar | Crossref | Medline35. Wong, MCs, Huang, J, Lai, C, et al. Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19: a meta-analysis. J Infect 2020; 81(2): e31–e38. doi: 10.1016/j.jinf.2020.06.012. Epub 2020 Jun 11.
Google Scholar | Crossref | Medline36. Ayling, RM, Kok, K. Fecal calprotectin. Adv Clin Chem 2018; 87: 161–190.
Google Scholar | Crossref | Medline37. Wang, Y, Wang, Y, Chen, Y, et al. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol 2020; 92: 568–576. doi: 10.1002/jmv.25748.
Google Scholar | Crossref | Medline38. Wu, Z, McGoogan, JM. Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242. doi: 10.1001/jama.2020.2648
Google Scholar | Crossref | Medline39. Wu, Y, Guo, C, Tang, L, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020; 5: 434–435.
Google Scholar | Crossref | Medline40. Rizzo, R, Neri, LM, Simioni, C, et al. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient. Clin Microbiol Infect 2021. doi: 10.1016/j.cmi.2021.01.012.
Google Scholar | Crossref | Medline